Potential Association of Anti-CCR4 Antibody Mogamulizumab and Graft-vs-Host Disease in Patients With Mycosis Fungoides and Sézary Syndrome

This case series describes the occurrence of graft-vs-host-disease (GVHD) in patients with cutaneous T-cell lymphomas (CTCLs) treated with the CC chemokine receptor 4 (CCR4) antibody mogalizumab prior to allogeneic hematopoietic stem cell transplantation (HSCT).

Shranjeno v:
Bibliografske podrobnosti
izdano v:JAMA Dermatol
Main Authors: Dai, Julia, Almazan, Timothy H., Hong, Eric K., Khodadoust, Michael S., Arai, Sally, Weng, Wen-Kai, Kim, Youn H.
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2018
Teme:
Research Letter
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6145646/
https://ncbi.nlm.nih.gov/pubmed/29800117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2018.0884
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki